H. Lundbeck A/S operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other
companies in this sector in the United States:
Dr.Reddy's Laboratories Ltd
sales of $2.36 billion
of which 83%
was Global Generics),
Hikma Pharmaceuticals PLC
of which 40%
was Injectable Pharmaceuticals), and
of which 44%
was Drug Delivery Solutions).
H. Lundbeck A/S reported sales of $2.32 billion
December of 2016.
increase of 7.4%
versus 2015, when the company's sales were $2.16 billion.
Despite this increase, sales are still
below the level achieved in 2014, when H. Lundbeck A/S
reported sales of $2.39 billion.